Oral Chemotherapy for Treatment of Lung Cancer

Oral Chemotherapy for Treatment of Lung Cancer

The global COVID-19 pandemic has disrupted healthcare delivery, particularly for patients with advanced lung cancer. While certain aspects of care can be safely omitted or delayed, systemic therapy plays an important role in survival and quality of life for patients with advanced lung cancer; limiti...

Full description

Bibliographic Details
Main Authors:	Sushma Jonna, Joshua E. Reuss, Chul Kim, Stephen V. Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-04-01
Series:	Frontiers in Oncology
Subjects:	oral therapy chemotherapy capecitabine temozolomide topotecan vinorelbine
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.00793/full

Similar Items

Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
by: Katharine Thomas, et al.
Published: (2020-01-01)

Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
by: Sumana Devata, et al.
Published: (2012-11-01)

Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
by: V. Sgroi, et al.
Published: (2018-01-01)

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
by: Kotteas EA, et al.
Published: (2016-02-01)

Gemcitabine Combined with Vinorelbine in the Treatment of Refractory Patients with Advanced Non-small Cell Lung Cancer: A Multi-center Retrospective Study
by: Shun LU, et al.
Published: (2012-09-01)

Oral vinorelbine: a feasible and safe partner for radiotherapy in the treatment of locally advanced non-small cell lung cancer
by: Perri F, et al.
Published: (2016-04-01)

Treatment of Extra — Abdominal Desmoid Tumors with Chemotherapy
by: H. Thomas Temple, et al.
Published: (2011-08-01)

Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma
by: Filiz Senbabaoglu, et al.
Published: (2020-12-01)

Combined Chemotherapy with Vinorelbine and Ifosfamide as Third-line Treatment and Beyond of Advanced Non-small Cell Lung Cancer
by: Yang ZHOU, et al.
Published: (2015-06-01)

Clinical Observation of Metronomic Oral Vinorelbine Monotherapy as First-line Treatment on Elderly Patients with Advanced Non-small Cell Lung Cancer
by: LIN Jinlan, et al.
Published: (2018-11-01)

Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma
by: Rong-Sheng Qin, et al.
Published: (2018-10-01)

A Prospective Randomized Study of Adjuvant Chemotherapy in Resected Stage IIIA-N2 Non-small Cell Lung Cancer
by: Haibo SUN, et al.
Published: (2009-09-01)

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience
by: Guo Q, et al.
Published: (2020-02-01)

Metastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review
by: Marie Cantaloube, et al.
Published: (2018-01-01)

Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer
by: Xue-Lian Chen, et al.
Published: (2016-04-01)

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience [Corrigendum]
by: Guo Q, et al.
Published: (2020-03-01)

MODERN POSSIBILITIES OF APPLICATION OF PREPARATION NAVELBINE® IN THE TREATMENT OF METASTATIC BREAST CANCER
by: L. V. Bolotina
Published: (2016-06-01)

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial
by: Guetz S, et al.
Published: (2017-02-01)

Oral vinorelbine: its role in advanced breast cancer pre-treated with anthracycline and taxane chemotherapies
by: Fausto Petrelli, et al.
Published: (2011-12-01)

Therapeutic uses of topotecan for thoracic malignancies
by: Saoirse O. Dolly, et al.
Published: (2011-12-01)

Adherence to oral antineoplastic therapy
by: R. Olivera-Fernandez, et al.
Published: (2014-04-01)

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
by: Cazzaniga ME, et al.
Published: (2019-04-01)

Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?
by: Lakshmi Chintala, et al.
Published: (2011-06-01)

Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer
by: Claudio Vernieri, et al.
Published: (2020-03-01)

Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study
by: Aktas G, et al.
Published: (2016-04-01)

Immediate Versus Delayed Topotecan after First-line Therapy in Small Cell Lung Cancer
by: Cong XUE, et al.
Published: (2010-03-01)

Adverse drug reaction after intravitreal injection of topotecan
by: Subina Narang, et al.
Published: (2020-01-01)

Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India
by: Pukhraj Rishi, et al.
Published: (2017-01-01)

Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy
by: Akinaru Yamamoto, et al.
Published: (2020-11-01)

Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
by: Anjie Zhu, et al.
Published: (2021-08-01)

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
by: Andrea Lania, et al.
Published: (2021-07-01)

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
by: Min Shi, et al.
Published: (2020-03-01)

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
by: Xiuwen Guan, et al.
Published: (2020-07-01)

Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
by: Renata Ferrarotto, et al.
Published: (2013-09-01)

CAPECITABINE AND IRINOTECAN AS FIRST- LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2010-11-01)

Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?
by: Klag N, et al.
Published: (2016-06-01)

The efficacy and safety of Oxaliplatin-Vinorelbine as a second-line chemotherapy combination in patients with platinum-resistant pretreated epithelial ovarian cancer: A retrospective study
by: Fidia Mumtahana, et al.
Published: (2014-12-01)

Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy
by: Salvatore Grisanti, et al.
Published: (2021-02-01)

Efficacy of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer: A real life experience and outcome from a tertiary referral centre.
by: Samia Yasmeen, et al.
Published: (2021-06-01)

IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER
by: E. M. Slonimskaya, et al.
Published: (2016-07-01)

Cannot write session to /tmp/vufind_sessions/sess_3310dkl17nusbdoaebqfpgp97i